|
Literature for OMIM 600513: EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1
Xenbase Articles:
(
Denotes literature images)
| Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation., Teper Y,Whyte D,Cahir E,Lester HA,Grady SR,Marks MJ,Cohen BN,Fonck C,McClure-Begley T,McIntosh JM,Labarca C,Lawrence A,Chen F,Gantois I,Davies PJ,Petrou S,Murphy M,Waddington J,Horne MK,Berkovic SF,Drago J, J Neurosci. September 19, 2007; 27(38):1529-2401. |
| Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy., Weltzin MM,Lindstrom JM,Lukas RJ,Whiteaker P, Neuropharmacology. March 1, 2016; 102:1873-7064. |
Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.,
Nichols WA,Henderson BJ,Marotta CB,Yu CY,Richards C,Dougherty DA,Lester HA,Cohen BN,
PLoS One. January 1, 2016; 11(6):1932-6203.
|
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery.,
O'Connor EC,Kambara K,Bertrand D,
Expert Opin Drug Discov. February 1, 2024; 19(2):1746-045X.
|
